Regulating Off-Label Info On Drugs, Medical Devices
In the waning days of the Bush administration, the U.S. Food and Drug Administration released a controversial new guidance document providing recommendations to manufacturers of drugs, medical devices and licensed biologics...To view the full article, register now.
Already a subscriber? Click here to view full article